Fairvalue-Calculator Fairvalue-Calculator
EN DE

RH Bophelo Limited (RHB) Fair Value & Analysis

Financial Services · ZA · Market cap 107M ZAC

Price1.65 ZAC
Fair Value3.30 ZAC
Upside+100.0%
Quality97/100
Evidence: High Range 2.48 ZAC – 4.13 ZAC

Fair value as of: Jun 26, 2026

✦ Screen 34,000+ stocks by fair value & quality — free Start the tool →

Analysis

RH Bophelo Limited (RHB) currently trades at 1.65 ZAC, while our model-based Fair Value estimate is 3.30 ZAC — implying the stock looks roughly 100.0% undervalued today. We read business quality at 97/100 (high quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

RH Bophelo Limited, together with its subsdidiaries, invests in the healthcare and financial sector in South Africa. It is involved in investment of equity, quasi-equity, and equity related investments in operational infrastructure, health insurance, private hospital infrastructure, pharmaceuticals, retail and distribution, and healthcare technology. The company was incorporated in 2016 and is based in Johannesburg, South Africa. RH Bophelo Limited operates as a subsidiary of Public Investment Corporation SOC Limited.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is RH Bophelo Limited (RHB) undervalued?
As of Jun 26, 2026, our model estimates a fair value of 3.30 ZAC versus a price of 1.65 ZAC — about +100% (undervalued). Model-based estimate, not financial advice.
What is the fair value of RHB?
Our 21-model fair value for RH Bophelo Limited is 3.30 ZAC (as of Jun 26, 2026), built from audited fundamentals. The current price is 1.65 ZAC.
What is the quality score of RHB?
RH Bophelo Limited has a Quality Score of 97/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.